Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;12(1):2074-2086.
doi: 10.1080/21655979.2021.1931640.

Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis

Affiliations
Review

Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis

Yuan Zhang et al. Bioengineered. 2021 Dec.

Abstract

APOBEC3 (A3) cytidine deaminases inhibit hepatitis B virus (HBV) infection and play vital roles in maintaining a variety of biochemical processes, including the regulation of protein expression and innate immunity. Emerging evidence indicates that the deaminated deoxycytidine biochemical activity of A3 proteins in single-stranded DNA makes them a double-edged sword. These enzymes can cause cellular genetic mutations at replication forks or within transcription bubbles, depending on the physiological state of the cell and the phase of the cell cycle. Under pathological conditions, aberrant expression of A3 genes with improper deaminase activity regulation may threaten genomic stability and eventually lead to cancer development. This review attempted to summarize the antiviral activities and underlying mechanisms of A3 editing enzymes in HBV infections. Moreover, the correlations between A3 genes and hepatocarcinogenesis were also elucidated.

Keywords: APOBEC3; Cancer; Hepatitis B virus; Hepatocellular carcinoma.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
The process of HBV infecting liver cells and mechanisms of A3 genes in anti-HBV

Similar articles

Cited by

References

    1. Silvas TV, Schiffer CA.. APOBEC3s: DNA-editing human cytidine deaminases. Protein Sci. 2019;28(9):1552–1566. - PMC - PubMed
    1. Knisbacher BA, Gerber D.. Levanon EY: DNA editing by APOBECs: a genomic preserver and transformer. Trends Genet. 2016;32(1):16–28. - PubMed
    1. Revathidevi S, Murugan AK, Nakaoka H, et al. Munirajan AK: APOBEC: a molecular driver in cervical cancer pathogenesis. Cancer Lett. 2021;496:104–116. - PMC - PubMed
    1. Hultquist JF, Lengyel JA, Refsland EW, et al. Harris RS: human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict vif-deficient HIV-1. J Virol. 2011;85(21):11220–11234. - PMC - PubMed
    1. Schmitt K, Guo K, Algaier M, et al. Stephens EB: differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution. Virology. 2011;419(1):24–42. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources